STMicroelectronics’ MEMS Dominance in MedTech
Published: April 2024
Medical Innovation:
0.1Pa-resolution nano-sensors enable Medtronic’s closed-loop insulin delivery.
FDA-cleared biosensing SoCs launch at CES 2024.
Market Data: 34% global MEMS revenue share maintained (Yole 2024 report).
Previous:Texas Instruments’ GaN Revolut